Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Immutep (IMMP) EBITDA (2016 - 2025)

Immutep filings provide 10 years of EBITDA readings, the most recent being -$41.6 million for Q2 2025.

  • On a quarterly basis, EBITDA fell 35.72% to -$41.6 million in Q2 2025 year-over-year; TTM through Jun 2025 was -$88.4 million, a 104.98% decrease, with the full-year FY2025 number at -$39.3 million, down 39.78% from a year prior.
  • EBITDA hit -$41.6 million in Q2 2025 for Immutep, down from -$17.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $1.2 million in Q4 2023 to a low of -$41.6 million in Q2 2025.
  • Median EBITDA over the past 5 years was -$15.7 million (2024), compared with a mean of -$17.0 million.
  • Biggest five-year swings in EBITDA: plummeted 3431.95% in 2022 and later surged 108.78% in 2023.
  • Immutep's EBITDA stood at $422694.3 in 2021, then plummeted by 3431.95% to -$14.1 million in 2022, then surged by 108.78% to $1.2 million in 2023, then crashed by 1496.9% to -$17.3 million in 2024, then crashed by 141.04% to -$41.6 million in 2025.
  • The last three reported values for EBITDA were -$41.6 million (Q2 2025), -$17.3 million (Q4 2024), and -$30.7 million (Q2 2024) per Business Quant data.